References
- Elliott JO, Moore JL, Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 behavioral risk factor surveillance system. EPILEPSY BEHAV. 2008;12(3):434–444.
- Syed TU, Sajatovic M. Extended-release lamotrigine in the treatment of patients with epilepsy. Expert Opin Pharmaco. 2010;11(9):1579–1585.
- Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446–456.
- Labate A, Fortunato F, Giugno A, et al. Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study. NEUROL SCI. 2021;42(4):1389–1394.
- Toledo M, Beale R, Evans JS, et al. Long-term retention rates for antiepileptic drugs: a review of long-term extension studies and comparison with brivaracetam. EPILEPSY RES. 2017;138:53–61.
- Baulac M, Brodie MJ, Patten A, et al. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. LANCET NEUROL. 2012;11(7):579–588.
- Zaccara G, Giovannelli F, Giorgi FS, et al. Tolerability of new antiepileptic drugs: a network meta-analysis. EUR J CLIN PHARMACOL. 2017;73(7):811–817.
- Chapman SC, Horne R, Eade R, et al. Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs. EPILEPSIA. 2015;56(9):1398–1407.
- Al-Aqeel S, Gershuni O, Al-Sabhan J, et al. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. COCHRANE DB SYST REV. 2017;2:D8312. •• Detailed introduction of strategies for improving adherence to antiepileptic drug treatment.
- Garnett WR. Lamotrigine: pharmacokinetics. J CHILD NEUROL. 1997;12 Suppl 1(1_suppl):S10–S15.
- Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. EPILEPSIA. 2017;58(4):512–521.
- Simister RJ, Sander JW, Koepp MJ. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. EPILEPSY BEHAV. 2007;10(2):336–339.
- Mohanraj R, Brodie MJ. Measuring the efficacy of antiepileptic drugs. SEIZURE-EUR J EPILEP. 2003;12:413–443.
- Warshavsky A, Eilam A, Gilad R. Lamotrigine as monotherapy in clinical practice: efficacy of various dosages in epilepsy. BRAIN BEHAV. 2016;6:e419. • Focus on lamotrigine as monotherapy in clinical practice.
- Bootsma HP, Ricker L, Hekster YA, et al. The impact of side effects on long-term retention in three new antiepileptic drugs. SEIZURE-EUR J EPILEP. 2009;18(5):327–331.
- Chung S, Wang N, Hank N. Comparative retention rates and long-term tolerability of new antiepileptic drugs. SEIZURE-EUR J EPILEP. 2007;16(4):296–304.
- Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine monotherapy trial group. LANCET. 1995;345(8948):476–479.
- Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. EPILEPSY RES. 1999;37(1):81–87.
- Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American academy of neurology and the American epilepsy society. NEUROLOGY. 2015;84(16):1705–1713.
- Lattanzi S, Brigo F, Cagnetti C, et al. Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy. Core Evid. 2018;13:21–31.
- Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722–732.
- Chandra IS, Kumar KL, Reddy MP, et al. Attitudes toward medication and reasons for non-compliance in patients with Schizophrenia. INDIAN J PSYCHOL MED. 2014;36(3):294–298.